December 16, 2021
A letter from Cergentis' CEO
June 01, 2021
Cergentis joins the NIST Genome Editing Consortium to further improve the quality of genetic research
July 14, 2020
TLA for enhanced Apollo X CHO clone screening
May 20, 2020
Novalis Biotech Incubation to invest in Cergentis
April 20, 2020
Automated TLA protocol: new PerkinElmer & Cergentis application note
See how our proprietary genomic analysis platform compares to conventional approaches such as WGS and FISH
Read application notes published by Cergentis and its partners.
Our TLA-based genetic QC solutions have been widely published and recognized. View more than 50 peer-reviewed papers, published by our customers and partners.
Watch our webinar recordings to find out more information about our genetic QC solutions in various applications.